Institutional Ownership
Aligos Therapeutics Inc
CUSIP 01626L204COM NEWALGSQ1 2026
13D / 13G Filings
18
Schedule 13D/13G on record
Beneficial Filers
11
Distinct reporting persons
Largest Stake
10.0%
Max % of class reported
Institutional Holders
31
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
18 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Woodline Partners LP | 13G/A | 5.4% | 289.2K | SEC |
| 2 | Feb 11, 2026 | Sio Capital Management, LLC | 13G/A | 5.5% | 335.9K | SEC |
| 3 | Nov 14, 2025 | Woodline Partners LP | 13G/A | 8.7% | 468.2K | SEC |
| 4 | Aug 14, 2025 | Woodline Partners LP | 13G/A | 9.8% | 518.3K | SEC |
| 5 | Aug 13, 2025 | Sio Capital Management, LLC | 13G | 5.5% | 355.9K | SEC |
| 6 | Aug 12, 2025 | Adage Capital Management, L.P. | 13G/A | 3.9% | 210.0K | SEC |
| 7 | May 15, 2025 | Alyeska Investment Group, L.P. | 13G | 10.0% | 530.0K | SEC |
| 8 | May 15, 2025 | Ecor1 Capital, LLC | 13G/A | 3.9% | — | SEC |
| 9 | May 15, 2025 | Woodline Partners LP | 13G | 5.2% | 315.4K | SEC |
| 10 | Mar 12, 2025 | Lawrence M. Blatt, Ph.D. | 13D/A | 3.2% | — | SEC |
8 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Aligos Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Deep Track Capital, LP | 444.1K | $3.30M |
| 2 | Alyeska Investment Group, L.P. | 412.0K | $3.06M |
| 3 | Sio Capital Management, LLC | 327.2K | $2.43M |
| 4 | Marshall Wace, LLP | 267.1K | $1.98M |
| 5 | Bank Of America Corp /De/ | 229.8K | $1.71M |
| 6 | Woodline Partners LP | 177.4K | $1.32M |
| 7 | Summittx Capital, L.P. | 148.8K | $1.11M |
| 8 | Renaissance Technologies LLC | 100.5K | $746.3K |
| 9 | Baker Bros. Advisors LP | 83.1K | $617.1K |
| 10 | Hhlr Advisors, Ltd. | 76.2K | $566.5K |